Skip to main content
. 2011 Jul 19;105(4):493–497. doi: 10.1038/bjc.2011.267

Table 1. Key variables in clinical stage I OGCT patients.

Variable LND-1a (%) LND+1b (%) LND+3Cc (%) P
Age
 Mean 24.2 25.2 22.7 NS
 Median 22 23 21.5  
         
Race
 W 437 (52.97) 343 (41.58) 45 (5.45) 0.07
 AA 72 (64.9) 35 (31.5) 4 (3.6)  
 O 81 (55.1) 63 (42.9) 3 (2.0)  
         
Clinical stage
 Stage IA 434 (55.7) 316 (40.6) 29 (3.7) 0.009
 Stage IB 11 (36.6) 17 (56.7) 2 (6.7)  
 Stage IC 105 (49.1) 91 (42.5) 18 (8.4)  
 Stage I NOS 40 (66.7) 17 (28.3) 3 (5.0)  
         
Grade MT only
 Grade I 92 (72.4) 33 (26.0) 2 (1.6) 0.052
 Grades II–IV 168 (60.2) 107 (38.4) 4 (1.4)  
         
Histology
 Dysgerminoma 133 (37.6) 181 (51.1) 40 (11.3) <0.001
 MT 338 (65.5) 171 (33.1) 7 (1.4)  
 MGCT/PNDCT 119 (55.8) 89 (41.8) 5 (2.4)  
         
Status
 Alive 569 (96.4) 429 (97.3) 49 (94.2) 0.45
 Dead 21 (3.6) 12 (2.7) 3 (5.8)  

Abbreviations: MGCT/PNCT=mixed germ cell tumour with pure nondysgerminoma cell tumour; MT=malignant teratoma; OGCT=ovarian germ cell tumour.

a

LND−1=patients with clinical stage I and no lymphadenectomy.

b

LND+1=patients with lymphadenectomy and histologically negative nodes.

c

LND+3=patients with lymphadenectomy and histologically positive nodes.